198 related articles for article (PubMed ID: 31991903)
1. Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure.
Świątkiewicz I; Magielski P; Kubica J; Zadourian A; DeMaria AN; Taub PR
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991903
[TBL] [Abstract][Full Text] [Related]
2. C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure over a Multi-Year Period.
Świątkiewicz I; Magielski P; Kubica J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804661
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
[TBL] [Abstract][Full Text] [Related]
4. Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction.
Zhu Y; Liu K; Meng S; Jia R; Lei X; Chen M; Zou K; Zhu H; Jin Z
Cardiovasc Diabetol; 2020 Jul; 19(1):101. PubMed ID: 32622355
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.
Swiatkiewicz I; Kozinski M; Magielski P; Gierach J; Fabiszak T; Kubica A; Sukiennik A; Navarese EP; Odrowaz-Sypniewska G; Kubica J
Inflamm Res; 2012 Jul; 61(7):725-34. PubMed ID: 22446726
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure.
Swiatkiewicz I; Taub PR
Kardiol Pol; 2018; 76(5):821-829. PubMed ID: 29633232
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes.
López-Castillo M; Aceña Á; Pello-Lázaro AM; Viegas V; Merchán Muñoz B; Carda R; Franco-Peláez J; Martín-Mariscal ML; Briongos-Figuero S; Tuñón J
Ann Noninvasive Electrocardiol; 2021 Jan; 26(1):e12791. PubMed ID: 32845542
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in ST- elevation myocardial infarction: risk factors, patterns of presentation and association with clinical picture and outcome, an observational study conducted at the Institute of Cardiology-National Hospital of Sri Lanka.
Navinan MR; Mendis S; Wickramasinghe S; Kathirgamanathan A; Fernando T; Yudhisdran J
BMC Cardiovasc Disord; 2019 May; 19(1):111. PubMed ID: 31088357
[TBL] [Abstract][Full Text] [Related]
9. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
Velazquez EJ; Francis GS; Armstrong PW; Aylward PE; Diaz R; O'Connor CM; White HD; Henis M; Rittenhouse LM; Kilaru R; van Gilst W; Ertl G; Maggioni AP; Spac J; Weaver WD; Rouleau JL; McMurray JJ; Pfeffer MA; Califf RM;
Eur Heart J; 2004 Nov; 25(21):1911-9. PubMed ID: 15522470
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up.
Vanhaverbeke M; Veltman D; Pattyn N; De Crem N; Gillijns H; Cornelissen V; Janssens S; Sinnaeve PR
Clin Cardiol; 2018 Sep; 41(9):1201-1206. PubMed ID: 29952015
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress markers predict early left ventricular systolic dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.
Rajic D; Jeremic I; Stankovic S; Djuric O; Zivanovic-Radnic T; Mrdovic I; Mitrovic P; Matic D; Vasiljevic Z; Matic M; Asanin M
Adv Clin Exp Med; 2018 Feb; 27(2):185-191. PubMed ID: 29521061
[TBL] [Abstract][Full Text] [Related]
12. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
[TBL] [Abstract][Full Text] [Related]
13. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction--contribution of cystatin C assessment.
Derzhko R; Plaksej R; Przewlocka-Kosmala M; Kosmala W
Coron Artery Dis; 2009 Nov; 20(7):453-61. PubMed ID: 19741512
[TBL] [Abstract][Full Text] [Related]
14. Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction.
Li JW; Chen YD; Liu YQ; Wang JD; Chen WR; Zhang YQ; Ma Q
Sci Rep; 2017 Jul; 7(1):6097. PubMed ID: 28733630
[TBL] [Abstract][Full Text] [Related]
15. Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
Moroni F; Corna G; Del Buono MG; Golino M; Talasaz AH; Decotto S; Markley R; Trankle C; Biondi-Zoccai G; Carbone S; Agatiello CR; Van Tassell B; Abbate A
Int J Cardiol; 2024 Mar; 398():131610. PubMed ID: 38016623
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Taniguchi T; Shiomi H; Morimoto T; Watanabe H; Ono K; Shizuta S; Kato T; Saito N; Kaji S; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Horie M; Kimura T
Am J Cardiol; 2017 Jun; 119(11):1729-1739. PubMed ID: 28407886
[TBL] [Abstract][Full Text] [Related]
17. Presence of post-systolic shortening is an independent predictor of heart failure in patients following ST-segment elevation myocardial infarction.
Brainin P; Haahr-Pedersen S; Sengeløv M; Olsen FJ; Fritz-Hansen T; Jensen JS; Biering-Sørensen T
Int J Cardiovasc Imaging; 2018 May; 34(5):751-760. PubMed ID: 29230597
[TBL] [Abstract][Full Text] [Related]
18. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
[TBL] [Abstract][Full Text] [Related]
19. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Park Y; Tantry US; Koh JS; Ahn JH; Kang MG; Kim KH; Jang JY; Park HW; Park JR; Hwang SJ; Park KS; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
Thromb Haemost; 2017 May; 117(5):911-922. PubMed ID: 28150852
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction.
Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
